Appendix 2—table 47. Antidepressant Non-user Cohort (Region=New York State) by BP Use, Patient Characteristics Pre/Post Match of BP Users/Non-users.
| Region=NY Antidepressant Non-users by BP: Unadjusted | Region=NY Antidepressant Non-users by BP: Matched | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All | BP Non-user | BP User | p-value | All | BP Non-user | BP User | p-value | |||||||
| N | % | N | % | N | % | N | % | N | % | N | % | |||
| All Patients | 135,516 | 100.0% | 125,342 | 92.5% | 10,174 | 7.5% | 20,182 | 100.0% | 10,091 | 50.0% | 10,091 | 50.0% | ||
| Age | ||||||||||||||
| ≤20 | 4,365 | 3.2% | 4,364 | 3.5% | 1 | 0.0% | <0.001 | 2 | 0.0% | 1 | 0.0% | 1 | 0.0% | 1.00 |
| 21-40 | 22,832 | 16.8% | 22,799 | 18.2% | 33 | 0.3% | 66 | 0.3% | 33 | 0.3% | 33 | 0.3% | ||
| 41-50 | 18,483 | 13.6% | 18,350 | 14.6% | 133 | 1.3% | 267 | 1.3% | 134 | 1.3% | 133 | 1.3% | ||
| 51-60 | 29,481 | 21.8% | 28,038 | 22.4% | 1,443 | 14.2% | 2,879 | 14.3% | 1,440 | 14.3% | 1,439 | 14.3% | ||
| 61-70 | 27,543 | 20.3% | 24,197 | 19.3% | 3,346 | 32.9% | 6,686 | 33.1% | 3,345 | 33.1% | 3,341 | 33.1% | ||
| 71-80 | 21,038 | 15.5% | 17,695 | 14.1% | 3,343 | 32.9% | 6,589 | 32.6% | 3,294 | 32.6% | 3,295 | 32.7% | ||
| ≥81 | 11,774 | 8.7% | 9,899 | 7.9% | 1,875 | 18.4% | 3,693 | 18.3% | 1,844 | 18.3% | 1,849 | 18.3% | ||
| Gender | ||||||||||||||
| Female | 96,468 | 71.2% | 86,945 | 69.4% | 9,523 | 93.6% | <0.001 | 18,892 | 93.6% | 9,446 | 93.6% | 9,446 | 93.6% | 1.00 |
| Male | 39,048 | 28.8% | 38,397 | 30.6% | 651 | 6.4% | 1,290 | 6.4% | 645 | 6.4% | 645 | 6.4% | ||
| Insurance | ||||||||||||||
| Commercial | 51,829 | 38.2% | 50,405 | 40.2% | 1,424 | 14.0% | <0.001 | 2,848 | 14.1% | 1,425 | 14.1% | 1,423 | 14.1% | 1.00 |
| Dual | 1,591 | 1.2% | 1,210 | 1.0% | 381 | 3.7% | 690 | 3.4% | 345 | 3.4% | 345 | 3.4% | ||
| Medicaid | 38,569 | 28.5% | 36,303 | 29.0% | 2,266 | 22.3% | 4,449 | 22.0% | 2,226 | 22.1% | 2,223 | 22.0% | ||
| Medicare | 43,527 | 32.1% | 37,424 | 29.9% | 6,103 | 60.0% | 12,195 | 60.4% | 6,095 | 60.4% | 6,100 | 60.4% | ||
| PCP Visit 2019 | ||||||||||||||
| No | 53,397 | 39.4% | 50,515 | 40.3% | 2,882 | 28.3% | <0.001 | 5,723 | 28.4% | 2,863 | 28.4% | 2,860 | 28.3% | 0.96 |
| Yes | 82,119 | 60.6% | 74,827 | 59.7% | 7,292 | 71.7% | 14,459 | 71.6% | 7,228 | 71.6% | 7,231 | 71.7% | ||
| Continuous Outcomes | ||||||||||||||
| mean | SD | mean | SD | mean | SD | p-value | mean | SD | mean | SD | mean | SD | p-value | |
| CCI | 0.96 | 1.68 | 0.95 | 1.66 | 1.13 | 1.81 | <0.001 | 1.11 | 1.77 | 1.11 | 1.76 | 1.12 | 1.78 | 0.78 |
BP: bisphosphonate; CCI: Charlson Comorbidity Index; PCP: primary care physician; SD: standard deviation.